Company: SNWV
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023881
Chunk: 69

Company: SANUWAVE Health, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 8
Chunk 69
---
 Company for the three months ended March 31, 2025. Total unrecognized compensation cost related to equity awards as of March 31, 2025 was $8.9 million and is expected to be recognized over the next 2.75 years. The Company recognizes compensation expense on a straight-line basis over the requisite service period, net of actual forfeitures.Three Months Ended March 31,(in thousands)2025Cost of sales9 General and administrative792 Selling and marketing158Research and development16Total expense$975 The following table presents a summary of stock options award activity during the three months ended March 31, 2025:Number of Options (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value (in thousands)Outstanding, December 31, 20241,137 $15.97 9.5$9,305 Granted176 27.42 7.81,393 Forfeited(80)0.0- Outstanding, March 31, 20251,233 $17.37 9.1$22,883 Exercisable, March 31, 2025207 $21.82 7.5$3,499 

17

Valuation Information for Stock-Based CompensationThe fair value of each stock option award during the three months ended March 31, 2025 was based on the closing price of the Company's common stock on the date of the grant. Expected volatility was based on 100% of the historical realized volatilities of peer companies. The risk-free interest rate was based on the implied yield for U.S. Treasury zero-coupon issue with the remaining term equal to the expected term. The expected holding period was calculated using the simplified method. No dividend was assumed as the Company does not pay regular dividends on its common stock and does not anticipate paying any dividends in the foreseeable future. The Company's policy is to recognize forfeitures as they occur.The weighted average assumptions used in the Black-Scholes option pricing model in valuing stock options granted in the three months ended March 31, 2025 are summarized in the table below:Three Months Ended March 31,2025Fair value at grant date$27.47Expected volatility62%Risk-free interest rate4%Expected holding period, in years5.45Dividend yield0%

14.       Loss per Share

Basic net loss per share is calculated